Publication | Open Access
The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with <i>MDM2</i> and <i>CDK4</i> amplification
41
Citations
20
References
2020
Year
We provide a new tool, the LeSS, for the prediction of malignant behaviour in LCTs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1